Company Profile
PAREXEL International
Company Overview
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in approximately 70 locations throughout over 50 countries around the world, and has over 11,000 employees. For more information about PAREXEL International visit www.PAREXEL.com.
Company History
PAREXEL grew and became a public company in 1995.
• Originally specialized in regulatory affairs services, which is now a very important but smaller part of our overall business
Significantly expanded our services to full clinical trials management in 1986
• Successful initial public offering (IPO) November 22, 1995
Secondary offering March 1996
• Continuing to grow at a fast pace by successfully servicing our customers and by adding and providing new services.
